Hypertensive Emergency Secondary to Combining Psilocybin Mushrooms, Extended Release Dextroamphetamine-Amphetamine, and Tranylcypromine.

Autor: Barnett BS; Department of Psychiatry and Psychology, Neurological Institute, Cleveland Clinic, Cleveland, OH, USA.; Cleveland Clinic, Cleveland Clinic Lerner College of Medicine at Case Western Reserve University, Cleveland, OH, USA., Koons CJ; Department of Anesthesia, Pikeville Medical Center, Pikeville, KY, USA., Van den Eynde V; PsychoTropical Research, Bucasia, QLD, Australia.; Department of Psychiatry, RadboudUMC, Nijmegen, The Netherlands., Gillman PK; PsychoTropical Research, Bucasia, QLD, Australia., Bodkin JA; Department of Psychiatry, McLean Hospital, Belmont, MA, USA.; Department of Psychiatry, Harvard Medical School, Boston, MA, USA.

Publikováno v: Journal of psychoactive drugs [J Psychoactive Drugs] 2024 Jun 21, pp. 1-7. Date of Electronic Publication: 2024 Jun 21.

Moving on With Monoamine Oxidase Inhibitors.

Autor: Bodkin JA; Department of Psychiatry, McLean Hospital, Harvard Medical School, Belmont (Bodkin); Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta (Dunlop)., Dunlop BW; Department of Psychiatry, McLean Hospital, Harvard Medical School, Belmont (Bodkin); Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta (Dunlop).

Publikováno v: Focus (American Psychiatric Publishing) [Focus (Am Psychiatr Publ)] 2021 Jan; Vol. 19 (1), pp. 50-52. Date of Electronic Publication: 2021 Jan 25.

Treatment of Negative Symptoms in Schizophrenia and Schizoaffective Disorder by Selegiline Augmentation of Antipsychotic Medication

Autor: Bodkin Ja, Sophie Cannon, Gwen Zornberg, Melinda Salomon, Bruce M. Cohen, Jonathan O. Cole

Publikováno v: The Journal of Nervous and Mental Disease. 184:295-301

It has been suggested that schizophrenic negative symptoms may be manifestations of regionally deficient CNS dopaminergic activity. We sought to test this hypothesis by openly treating patients on chronic antipsychotic medication who showed prominent

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58df2c2ad94be3a35e89a6419032b1da
https://doi.org/10.1097/00005053-199605000-00005

Targeted Treatment of Individuals With Psychosis Carrying a Copy Number Variant Containing a Genomic Triplication of the Glycine Decarboxylase Gene.

Autor: Bodkin JA; McLean Hospital, Belmont, Massachusetts; Department of Psychiatry, Harvard Medical School, Boston, Massachusetts., Coleman MJ; McLean Hospital, Belmont, Massachusetts; Department of Psychiatry, Harvard Medical School, Boston, Massachusetts., Godfrey LJ; McLean Hospital, Belmont, Massachusetts., Carvalho CMB; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas., Morgan CJ; Department of Biostatistics, University of Alabama at Birmingham, Birmingham, Alabama. Electronic address: cjmorgan@uab.edu., Suckow RF; New York State Psychiatric Institute, New York., Anderson T; McLean Hospital, Belmont, Massachusetts., Öngür D; McLean Hospital, Belmont, Massachusetts; Department of Psychiatry, Harvard Medical School, Boston, Massachusetts., Kaufman MJ; McLean Hospital, Belmont, Massachusetts; Department of Psychiatry, Harvard Medical School, Boston, Massachusetts., Lewandowski KE; McLean Hospital, Belmont, Massachusetts; Department of Psychiatry, Harvard Medical School, Boston, Massachusetts., Siegel AJ; McLean Hospital, Belmont, Massachusetts; Department of Medicine, Harvard Medical School, Boston, Massachusetts., Waldstreicher E; Deceased., Grochowski CM; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas., Javitt DC; Columbia University Medical Center, New York; Nathan Kline Institute, Orangeburg, New York., Rujescu D; Department of Psychiatry, Psychotherapy, and Psychosomatics, Martin Luther University of Halle-Wittenberg, Halle, Germany., Hebbring S; Center for Human Genetics, Marshfield Clinic Research Institute, Marshfield, Wisconsin., Weinshilboum R; Mayo Clinic, Rochester, Minnesota., Rodriguez SB; McLean Hospital, Belmont, Massachusetts., Kirchhoff C; Bozeman-Deaconess Hospital, Bozeman, Montana., Visscher T; Student Health Service, Montana State University, Bozeman, Montana., Vuckovic A; McLean Hospital, Belmont, Massachusetts; Department of Psychiatry, Harvard Medical School, Boston, Massachusetts., Fialkowski A; Department of Biostatistics, University of Alabama at Birmingham, Birmingham, Alabama., McCarthy S; Cold Spring Harbor Laboratory, Cold Spring Harbor, New York., Malhotra D; Hoffman-LaRoche Ltd., Basel, Switzerland., Sebat J; Department of Psychiatry, University of California, San Diego, La Jolla, California., Goff DC; Department of Psychiatry, New York University Langone Medical Center, New York; Nathan Kline Institute, Orangeburg, New York., Hudson JI; McLean Hospital, Belmont, Massachusetts; Department of Psychiatry, Harvard Medical School, Boston, Massachusetts., Lupski JR; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas., Coyle JT; McLean Hospital, Belmont, Massachusetts; Department of Psychiatry, Harvard Medical School, Boston, Massachusetts., Rudolph U; McLean Hospital, Belmont, Massachusetts; Department of Psychiatry, Harvard Medical School, Boston, Massachusetts., Levy DL; McLean Hospital, Belmont, Massachusetts; Department of Psychiatry, Harvard Medical School, Boston, Massachusetts.

Publikováno v: Biological psychiatry [Biol Psychiatry] 2019 Oct 01; Vol. 86 (7), pp. 523-535. Date of Electronic Publication: 2019 May 09.

Opioidergic Agents as Antidepressants: Rationale and Promise.

Autor: Saxena PP; Brockton Neighborhood Health Center, 63 Main St, Brockton, MA, 02301, USA. parnika_29@hotmail.com., Bodkin JA; McLean Hospital, 115 Mill St, North Belknap, Belmont, MA, 02478, USA.; Harvard Medical School, 25 Shattuck Street, Boston, MA, 02115, USA.

Publikováno v: CNS drugs [CNS Drugs] 2019 Jan; Vol. 33 (1), pp. 9-16.